Drug Shortage Report for OXALIPLATIN INJECTION

Last updated on 2019-07-16 History
Report ID 86908
Drug Identification Number 02435071
Brand name OXALIPLATIN INJECTION
Common or Proper name OXALIPLATIN
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) OXALIPLATIN
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 20ML
ATC code L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-06-18
Estimated end date 2019-07-30
Actual end date 2019-07-15
Shortage status Resolved
Updated date 2019-07-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2019-07-16 English Compare
v7 2019-07-15 French Compare
v6 2019-07-15 English Compare
v5 2019-06-27 French Compare
v4 2019-06-27 English Compare
v3 2019-06-19 English Compare
v2 2019-06-18 French Compare
v1 2019-06-18 English Compare

Showing 1 to 8 of 8